Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000557EBVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20001603HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20029318HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20031248HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TCGA Plot Options
Drug Information
GeneSLC6A4
DrugBank IDDB00988
Drug NameDopamine
Target IDBE0000749
UniProt IDP31645
Regulation Typeinhibitor
PubMed IDs11071707
CitationsRothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001 Jan;39(1):32-41.
GroupsApproved
Direct ClassificationCatecholamines and derivatives
SMILESNCCC1=CC(O)=C(O)C=C1
PathwaysRemifentanil Action Pathway; Hydrocodone Action Pathway; Sufentanil Action Pathway; Morphine Action Pathway; Fluoxetine Action Pathway; 3-Methylthiofentanyl Action Pathway; Benzocaine Action Pathway; Oxybuprocaine Action Pathway; Codeine Action Pathway; Alkaptonuria; Tyrosine Hydroxylase Deficiency; Ketobemidone Action Pathway; Propoxyphene Action Pathway; Dihydromorphine Action Pathway; Nicotine Action Pathway; Proparacaine Action Pathway; Methadyl Acetate Action Pathway; Hawkinsinuria; Oxymorphone Action Pathway; Fentanyl Action Pathway; Dimethylthiambutene Action Pathway; Dopamine beta-Hydroxylase Deficiency; Lidocaine (Local Anaesthetic) Action Pathway; Monoamine Oxidase-A Deficiency (MAO-A); Aromatic L-Aminoacid Decarboxylase Deficiency; Hydromorphone Action Pathway; Tyrosinemia, Transient, of the Newborn; Anileridine Action Pathway; Bupivacaine Action Pathway; Dopamine Activation of Neurological Reward System
PharmGKBPA449396
ChEMBLCHEMBL59